BCAX vs ZBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 23, 2026

BCAX

52.8
AI Score
VS
ZBIO Wins

ZBIO

58.5
AI Score

Investment Advisor Scores

BCAX

53score
Recommendation
HOLD

ZBIO

59score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric BCAX ZBIO Winner
Net Income -377.74M -111.65M BCAX
Operating Income -383.06M -120.19M BCAX
ROE -156.0% -23.8% BCAX
ROA -98.5% -21.8% BCAX
Total Assets 383.64M 512.24M BCAX
Cash 110.64M 96.60M ZBIO
Current Ratio 5.61 11.59 BCAX
Free Cash Flow -172.35M -81.83M BCAX

Relative Price Performance (Last 90 Days)

BCAX 1M: -25.2% · 3M: -39.7% ZBIO 1M: -14.6% · 3M: +7.0%

Current Technical Phase

BCAX

Markdown
Sell / avoid

Price below a falling SMA50 (slope -10.8%), weak momentum, RSI 24

RSI (14): 23.9 · Price: $17.63

ZBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 42

RSI (14): 41.9 · Price: $28.30

Fundamentals Snapshot

Metric BCAX ZBIO
Market Cap — —
Forward P/E -5.0 -6.1
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% -1.0%
Gross Margin — -212.5%
Operating Margin 0.0% -77.7%
EPS -3.00 -10.00
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, ZBIO is currently the stronger investment candidate, winning 1 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.